80 related articles for article (PubMed ID: 4701301)
1. In vivo and in vitro inhibition of the metabolism of N-alkyl-substituted amphetamines in rat by ferrocenylisopropylamine.
Vree TB; Henderson PT; von Rossum JM; Doukas PH
Xenobiotica; 1973 Jan; 3(1):23-35. PubMed ID: 4701301
[No Abstract] [Full Text] [Related]
2. Fenproporex N-dealkylation to amphetamine--enantioselective in vitro studies in human liver microsomes as well as enantioselective in vivo studies in Wistar and Dark Agouti rats.
Kraemer T; Pflugmann T; Bossmann M; Kneller NM; Peters FT; Paul LD; Springer D; Staack RF; Maurer HH
Biochem Pharmacol; 2004 Sep; 68(5):947-57. PubMed ID: 15294457
[TBL] [Abstract][Full Text] [Related]
3. Activation energies of alpha-C-oxidation and N-oxidation of N-alkyl-substituted amphetamines by rat liver microsomes. Stereochemistry and deuterium isotope effects.
Henderson PT; Vree TB; van Ginneken CA; van Rossum JM
Xenobiotica; 1974 Feb; 4(2):121-30. PubMed ID: 4828797
[No Abstract] [Full Text] [Related]
4. On the aromatic hydroxylation of amphetamine in rat liver microsomes and perfused liver preparations: effects of long-term administration.
Jonsson J
Acta Pharmacol Toxicol (Copenh); 1977 Apr; 40(4):517-28. PubMed ID: 16430
[TBL] [Abstract][Full Text] [Related]
5. The inhibitory effect of propranolol pretreatment on its own metabolism in the rat.
Schneck DW; Pritchard JF
J Pharmacol Exp Ther; 1981 Sep; 218(3):575-81. PubMed ID: 6267246
[TBL] [Abstract][Full Text] [Related]
6. The stimulation of lipid peroxidation produced by dimethylnitrosamine in rat liver microsomes in vitro: the effects of promethazine and inhibitors of drug metabolism, and a comparison with previous studies using carbon tetrachloride.
Jose PJ; Slater TF
Xenobiotica; 1973 Jun; 3(6):357-66. PubMed ID: 4148105
[No Abstract] [Full Text] [Related]
7. The influence of cytochrome P-450 induction on the metabolic formation of 455-NM complexes from amphetamines.
Franklin MR
Drug Metab Dispos; 1974; 2(3):321-6. PubMed ID: 4153124
[No Abstract] [Full Text] [Related]
8. Fate of isopropyl-iodoamphetamine (IMP) in rat liver microsomes.
Joulin Y; Moretti JL; Hoellinger H; Defer G
Nucl Med Commun; 1992 Feb; 13(2):99-105. PubMed ID: 1436904
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of rat liver CYP2D in vitro and after 1-day and long-term exposure to neuroleptics in vivo-possible involvement of different mechanisms.
Daniel WA; Haduch A; Wójcikowski J
Eur Neuropsychopharmacol; 2005 Jan; 15(1):103-10. PubMed ID: 15572279
[TBL] [Abstract][Full Text] [Related]
10. The inhibition of rat hepatic microsomal propranolol metabolism by a covalently bound reactive metabolite.
Pritchard JF; Schneck DW; Hayes AH
Res Commun Chem Pathol Pharmacol; 1980 Feb; 27(2):211-22. PubMed ID: 6768117
[TBL] [Abstract][Full Text] [Related]
11. Influence of classic and atypical neuroleptics on caffeine oxidation in rat liver microsomes.
Daniel WA; Kot M; Wójcikowski J
Pol J Pharmacol; 2003; 55(6):1055-61. PubMed ID: 14730101
[TBL] [Abstract][Full Text] [Related]
12. Metabolic activation of model pyrroles by cytochrome P-450.
Guengerich FP; Mitchell MB
Drug Metab Dispos; 1980; 8(1):34-8. PubMed ID: 6102027
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of halazepam by rat liver microsomes: stereoselective formation and N-dealkylation of 3-hydroxyhalazepam.
Lu XL; Yang SK
Chirality; 1990; 2(1):1-9. PubMed ID: 2400636
[TBL] [Abstract][Full Text] [Related]
14. Study of dose-dependent metabolism of 5,5-diphenyl-hydantoin in the rat using new methodology for isolation and quantitation of metabolites in vivo and in vitro.
Gerber N; Weller WL; Lynn R; Rangno RE; Sweetman BJ; Bush MT
J Pharmacol Exp Ther; 1971 Sep; 178(3):567-79. PubMed ID: 5571905
[No Abstract] [Full Text] [Related]
15. Selective involvement of cytochrome P450 2D subfamily in in vivo 4-hydroxylation of amphetamine in rat.
Law MY; Slawson MH; Moody DE
Drug Metab Dispos; 2000 Mar; 28(3):348-53. PubMed ID: 10681381
[TBL] [Abstract][Full Text] [Related]
16. In vitro metabolism of the antianxiety drug buspirone as a predictor of its metabolism in vivo.
Jajoo HK; Blair IA; Klunk LJ; Mayol RF
Xenobiotica; 1990 Aug; 20(8):779-86. PubMed ID: 2219961
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of deprenyl, a selective monoamine oxidase (MAO) B inhibitor in rat: relationship of metabolism to MAO-B inhibitory potency.
Yoshida T; Yamada Y; Yamamoto T; Kuroiwa Y
Xenobiotica; 1986 Feb; 16(2):129-36. PubMed ID: 3083608
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.
Mani C; Gelboin HV; Park SS; Pearce R; Parkinson A; Kupfer D
Drug Metab Dispos; 1993; 21(4):645-56. PubMed ID: 8104124
[TBL] [Abstract][Full Text] [Related]
19. Biotransformation of lovastatin. II. In vitro metabolism by rat and mouse liver microsomes and involvement of cytochrome P-450 in dehydrogenation of lovastatin.
Vyas KP; Kari PH; Prakash SR; Duggan DE
Drug Metab Dispos; 1990; 18(2):218-22. PubMed ID: 1971576
[TBL] [Abstract][Full Text] [Related]
20. Prediction of midazolam-CYP3A inhibitors interaction in the human liver from in vivo/in vitro absorption, distribution, and metabolism data.
Yamano K; Yamamoto K; Katashima M; Kotaki H; Takedomi S; Matsuo H; Ohtani H; Sawada Y; Iga T
Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):443-52. PubMed ID: 11259329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
